Affiliation:
1. Novosibirsk State Medical University; City Clinical Hospital No. 2
2. Novosibirsk State Medical University; Research Institute of Clinical and Experimental Lymphology — Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences
3. Novosibirsk State Medical University
4. Research Institute of Clinical and Experimental Lymphology — Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences
Abstract
BACKGROUND: Hodgkin’s lymphoma (HL) is one of the most common malignant lymphoproliferative diseases. Chemotherapy and radiotherapy used in the treatment of LH induce a number of toxic effects leading to dysfunction of endocrine system. Hormonal disorders in HL and their relationships with the therapy used remain to be clarified.AIM: To assess disorders of the endocrine function of thyroid, parathyroid glands and gonads in HL survivors.MATERIALS AND METHODS: Screening of endocrine dysfunction of the thyroid, parathyroid glands and gonads was performed in 160 adult patients with HL, 55 men and 105 women, at remission stage induced by chemotherapy or chemoradiotherapy. Forty healthy subjects, matched by age, were acted as control. The levels of TSH, T3, free T4, PTH, FSH, LH, free testosterone, dehydroepiandrosterone sulfate (DHEA-S), and sex-hormone binding globulin (SHBG) were measured in blood serum by ELISA. Bone mineral density (BMD) was assessed by DEXA.RESULTS: Hypothyroidism (25%), hyperparathyroidism (15.6%) and hypogonadism (29% of men and 25.3% of women) were the most prevalent endocrine disorders in LH survivors. Hypothyroidism was significantly more common in patients after chemoradiotherapy than in those who received only chemotherapy (χ2=9.4, р=0.002). In patients with hyperparathyroidism, there were negative correlations between PTH levels and BMD in the lumbar spine (r=-0.74, p=0.00002) and in the femoral neck (r=-0.66, p=0.0003). Men with HL demonstrated lower free testosterone concentrations when compared to control (p=0.04); LH and FSH levels were elevated (p=0.0004 and p=0.04, respectively). In men with HL the levels of DHEA-S were reduced (p=0.0009). The increased SHBG concentrations were revealed in 13 (23.6%) men. Women of reproductive age with HL had higher levels of LH in the luteal phase (p=0.05) and FSH in the follicular phase (p=0.02) than controls.CONCLUSION: The data indicate a high prevalence of the dysfunctions of thyroid, parathyroid glands, and gonads in HL survivors. Screening for endocrine disorders in these patients is highly recommended.
Publisher
Endocrinology Research Centre
Subject
Endocrinology, Diabetes and Metabolism
Reference20 articles.
1. Russian clinical guidelines on diagnosis and treatment of lymphoproliferative disorders. Ed. by IV Poddubnaya, VG Savchenko. Moscow: Buki Vedi Publ.; 2016. (In Russ.).
2. Kaseb H, Babiker H. Cancer, Lymphoma, Hodgkin. StatPearls Publishing: Treasure Island, USA (FL); 2018.
3. Master S, Koshy N, Wilkinson B, et al. Effect of radiation therapy on survival in Hodgkin’s lymphoma: A SEER data analysis. Anticancer Res. 2017;37(6):3035-3043. doi: https://doi.org/10.21873/anticanres.11658
4. Hodgson D. Long-term toxicity of chemotherapy and radiotherapy in lymphoma survivors: optimizing treatment for individual patients. Clin Adv Hematol Oncol. 2015;13(2):103-112.
5. Golounina OO, Pavlova MG, Belaya ZE, et al. Endocrine late-effects and bone mineral density after combined treatment of malignant brain tumors in childhood and adolescence. Problems of Endocrinology. 2021;67(1):31-40. (In Russ.). doi: https://doi.org/10.14341/probl12680
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献